OR10A2
geneOn this page
Also known as OST363
Summary
OR10A2 (olfactory receptor family 10 subfamily A member 2, HGNC:8161) is a protein-coding gene on chromosome 11p15.4, encoding Olfactory receptor 10A2 (Q9H208). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 341276 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 50 total
- MANE Select transcript:
NM_001004460
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8161 |
| Approved symbol | OR10A2 |
| Name | olfactory receptor family 10 subfamily A member 2 |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OST363 |
| Ensembl gene | ENSG00000170790 |
| Ensembl biotype | protein_coding |
| Entrez | 341276 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000641461
RefSeq mRNA: 1 — MANE Select: NM_001004460
NM_001004460
CCDS: CCDS31415
Canonical transcript exons
ENST00000641461 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003812383 | 6863057 | 6863351 |
| ENSE00003813412 | 6869623 | 6874717 |
Expression profiles
Bgee: expression breadth tissue_specific, 6 present calls, max score 78.95.
Top tissues by expression
120 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.95 | gold quality |
| colonic epithelium | UBERON:0000397 | 60.40 | gold quality |
| bone marrow cell | CL:0002092 | 59.96 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 50.75 | gold quality |
| stromal cell of endometrium | CL:0002255 | 49.32 | gold quality |
| bone marrow | UBERON:0002371 | 47.01 | gold quality |
| primary visual cortex | UBERON:0002436 | 45.99 | silver quality |
| tonsil | UBERON:0002372 | 41.89 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 41.78 | gold quality |
| ganglionic eminence | UBERON:0004023 | 38.72 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.83 | gold quality |
| calcaneal tendon | UBERON:0003701 | 36.92 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 36.90 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| cortex of kidney | UBERON:0001225 | 36.04 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 35.81 | gold quality |
| muscle tissue | UBERON:0002385 | 35.42 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.36 | gold quality |
| liver | UBERON:0002107 | 34.96 | gold quality |
| endometrium | UBERON:0001295 | 34.95 | gold quality |
| monocyte | CL:0000576 | 34.70 | gold quality |
| leukocyte | CL:0000738 | 34.53 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 34.27 | gold quality |
| adrenal tissue | UBERON:0018303 | 33.34 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 33.29 | gold quality |
| kidney | UBERON:0002113 | 32.87 | gold quality |
| nucleus accumbens | UBERON:0001882 | 32.37 | gold quality |
| caudate nucleus | UBERON:0001873 | 32.14 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 31.70 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.84 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or10a2 | ENSMUSG00000049674 |
| mus_musculus | Or10a5 | ENSMUSG00000073898 |
| rattus_norvegicus | Or10a5 | ENSRNOG00000087790 |
| rattus_norvegicus | Or10a2 | ENSRNOG00000090546 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310), OR2T10 (ENSG00000184022)
Protein
Protein identifiers
Olfactory receptor 10A2 — Q9H208 (reviewed: Q9H208)
Alternative names: HP4, Olfactory receptor OR11-86
All UniProt accessions (1): Q9H208
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004460* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (24 total): topological domain 8, transmembrane region 7, sequence variant 5, sequence conflict 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H208-F1 | 86.46 | 0.49 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 84–176
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, WP_GPCRS_OTHER, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
160 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR10A2 | GOLT1A | Q6ZVE7 | 530 |
| OR10A2 | VN1R4 | Q7Z5H5 | 518 |
| OR10A2 | DLEU7 | Q6UYE1 | 502 |
| OR10A2 | VN1R2 | Q8NFZ6 | 481 |
| OR10A2 | VN1R1 | Q9GZP7 | 431 |
| OR10A2 | HDHD3 | Q9BSH5 | 417 |
| OR10A2 | MRGPRX2 | Q96LB1 | 402 |
| OR10A2 | TAS2R13 | Q9NYV9 | 395 |
| OR10A2 | TAS2R5 | Q9NYW4 | 368 |
| OR10A2 | TAS2R31 | P59538 | 367 |
| OR10A2 | TAS2R50 | P59544 | 367 |
| OR10A2 | SUMF2 | Q8NBJ7 | 359 |
| OR10A2 | TAS2R10 | Q9NYW0 | 358 |
| OR10A2 | TAS2R4 | Q9NYW5 | 348 |
| OR10A2 | ZNF717 | Q9BY31 | 348 |
| OR10A2 | TAS2R43 | P59537 | 348 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A4D2G3, O43749, O76001, O76002, O76100, O95006, P0DMU2, P23266, P23269, P23272, P23274, P30953, P30955, P58173, P59922, P70526, Q13607, Q15619, Q60890, Q6UXT6, Q8N148, Q8N628, Q8NGA6, Q8NGL2, Q8NGS0, Q8NGS2, Q8NGX8, Q8NGZ4, Q8NGZ5, Q8NGZ6, Q8NH04, Q8VGI1, Q8VGK5, Q8VGR9, Q95156, Q96R09, Q96R47, Q96R48, Q96R84, Q9GZK6
Diamond homologs: A0A2R8YED5, O14581, O43749, O76099, O95221, P0C626, P0C7N1, P0C7N5, P0DN81, P23266, P23275, P30955, P47890, P58173, P58181, P59922, Q15617, Q15619, Q15622, Q60878, Q60881, Q60895, Q6IEU7, Q6UXT6, Q7TQQ0, Q7Z3T1, Q8N0Y5, Q8N146, Q8N162, Q8N628, Q8NG98, Q8NGA1, Q8NGC2, Q8NGE5, Q8NGF4, Q8NGF8, Q8NGG0, Q8NGG3, Q8NGG4, Q8NGG8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
211 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:6870036:T:TA | acceptor_gain | 0.9100 |
| 11:6870038:G:C | acceptor_gain | 0.7600 |
| 11:6870034:TTTGG:T | acceptor_gain | 0.7200 |
| 11:6870037:G:A | acceptor_gain | 0.7200 |
| 11:6869741:G:GG | donor_gain | 0.6900 |
| 11:6870036:TGG:T | acceptor_gain | 0.6700 |
| 11:6870471:T:G | acceptor_gain | 0.6600 |
| 11:6870481:A:G | acceptor_gain | 0.6400 |
| 11:6870333:G:GA | donor_gain | 0.6100 |
| 11:6870473:T:G | acceptor_gain | 0.5900 |
| 11:6870475:T:G | acceptor_gain | 0.5600 |
| 11:6870480:A:AG | acceptor_gain | 0.5600 |
| 11:6870376:A:AG | acceptor_gain | 0.5300 |
| 11:6869822:T:TA | acceptor_gain | 0.5200 |
| 11:6870035:TTGG:T | acceptor_gain | 0.5100 |
| 11:6870332:T:TA | donor_gain | 0.5100 |
| 11:6870414:G:T | donor_gain | 0.5100 |
| 11:6870474:A:AG | acceptor_gain | 0.5000 |
| 11:6870041:T:TA | acceptor_gain | 0.4900 |
| 11:6870407:C:G | donor_gain | 0.4900 |
| 11:6870472:A:AG | acceptor_gain | 0.4900 |
| 11:6870482:G:GG | acceptor_gain | 0.4900 |
| 11:6870414:G:GT | donor_gain | 0.4800 |
| 11:6870470:A:AG | acceptor_gain | 0.4800 |
| 11:6870477:A:AG | acceptor_gain | 0.4700 |
| 11:6870329:T:TA | donor_gain | 0.4500 |
| 11:6869738:TAA:T | donor_gain | 0.4300 |
| 11:6870039:A:AG | acceptor_gain | 0.4300 |
| 11:6870040:G:GG | acceptor_gain | 0.4300 |
| 11:6870279:C:A | donor_gain | 0.4300 |
AlphaMissense
1973 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:6870586:A:C | S278R | 0.939 |
| 11:6870588:C:A | S278R | 0.939 |
| 11:6870588:C:G | S278R | 0.939 |
| 11:6870256:A:C | S168R | 0.911 |
| 11:6870258:C:A | S168R | 0.911 |
| 11:6870258:C:G | S168R | 0.911 |
| 11:6870160:T:A | W136R | 0.893 |
| 11:6870160:T:C | W136R | 0.893 |
| 11:6870247:T:C | F165L | 0.884 |
| 11:6870249:C:A | F165L | 0.884 |
| 11:6870249:C:G | F165L | 0.884 |
| 11:6870594:A:C | R280S | 0.880 |
| 11:6870594:A:T | R280S | 0.880 |
| 11:6870481:A:C | S243R | 0.879 |
| 11:6870483:C:A | S243R | 0.879 |
| 11:6870483:C:G | S243R | 0.879 |
| 11:6870080:G:C | R109P | 0.877 |
| 11:6870069:G:A | M105I | 0.871 |
| 11:6870069:G:C | M105I | 0.871 |
| 11:6870069:G:T | M105I | 0.871 |
| 11:6870573:C:A | N273K | 0.870 |
| 11:6870573:C:G | N273K | 0.870 |
| 11:6870217:T:C | F155L | 0.869 |
| 11:6870219:C:A | F155L | 0.869 |
| 11:6870219:C:G | F155L | 0.869 |
| 11:6870466:T:C | F238L | 0.863 |
| 11:6870468:C:A | F238L | 0.863 |
| 11:6870468:C:G | F238L | 0.863 |
| 11:6870244:T:C | F164L | 0.859 |
| 11:6870246:C:A | F164L | 0.859 |
dbSNP variants (sampled 300 via entrez): RS1000214957 (11:6863735 G>A), RS1000658801 (11:6865577 T>C), RS1000719008 (11:6864043 A>G,T), RS1000974647 (11:6871263 T>C), RS1001176962 (11:6874876 T>A,C,G), RS1001586832 (11:6864766 G>C), RS1002002334 (11:6870726 T>A,C,G), RS1002155423 (11:6864291 A>C), RS1002584628 (11:6862843 G>A), RS1002718727 (11:6871852 T>C), RS1002971054 (11:6873928 T>C), RS1003109577 (11:6865242 A>C), RS1003162046 (11:6865555 C>T), RS1003533760 (11:6863844 C>A), RS1003604722 (11:6861613 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004691_20 | Huntington’s disease progression | 2.000000e-06 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008336 | disease progression measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Huntington disease